Department of Immunotechnology
11 – 20 of 114
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Investigation of per- and polyfluoroalkyl substances (PFAS) toxicity using a human dendritic cell model
(
- Master (Two yrs)
-
Mark
Microenvironment profiling of high-grade serous ovarian cancer
(
- Master (Two yrs)
-
Mark
Proteomics and Phosphoproteomics Analysis of Parental and Cisplatin-Resistant Ovarian Cancer Cell Lines Treated with C26A6 and Volasertib
(
- Master (Two yrs)
-
Mark
Activation of Antigen Presenting Cells Following Stimulation with a CD40-CEACAM5 Bispecific Antibody, in an ex vivo Esophagogastric Adenocarcinoma Model
(
- Master (Two yrs)
-
Mark
Exploring Tumor Modeling and Immunotoxicology - Precision-Cut Tumor Slices of Head and Neck Squamous Cell Carcinoma and Immune Response to Nanoplastics
(
- Master (Two yrs)
-
Mark
Proteomic characterisation of immune cells with a novel FACS-into-evotip workflow
(
- Master (Two yrs)
-
Mark
Dual peptide insertion in capsid of Adeno-associated virus
(
- Master (Two yrs)
- 2024
-
Mark
Establishment and Characterization of Innovative Immunoreagents for Diagnosis of Neurodegenerative Disease
(
- Master (Two yrs)
-
Mark
Investigating the Genetic Basis and Functional Implications of High-Affinity Antibodies Targeting Grass Pollen Allergen Phl p 5
(
- Master (Two yrs)
-
Mark
Evaluation of metalorganic complexes for their anti-mycobacterial properties in vitro for future tuberculosis therapy
(
- Master (Two yrs)